Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL554266

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(C3CCN3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O

Basic Information

ChEMBL ID CHEMBL554266
Phase Preclinical
Structure Type MOL
InChI Key DCQPVQNXGGXXQQ-JTDWFFLCSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

585.7
MW (Da)
2.17
ALogP
9
HBA
4
HBD
166.3
PSA (Ų)
0.29
QED
1
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C31H43N3O8
MW 585.70
Aromatic Rings 0
Heavy Atoms 42
NP-Likeness 2.54

Activity Summary

IC50 1 meas. best 7.77

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
SK-BR-3
CHEMBL613834
IC50 7.77 7.77 17.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
SK-BR-3 IC50 = 17.0 nM 7.77 Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... 7562911

Literature References

PubMed DOI Target Context # Activities
7562911 10.1021/jm00019a010 SK-BR-3 2

Data from ChEMBL 36 via Core Engine